astrazeneca glp 1 AZ to terminate once-daily cotadutide program to focus on weekly GLP-1RA co-agonist AstraZeneca, Eccogene Enter Exclusive License
Description
Lau D, Claudius B, Skjth TV, Bjrn Jensen C, P.H
But, in his nomination hearings, Oz failed to make any GLP-1 commitments, suggesting he may toe the line with Kennedy on any moves in this area
So the argument to be made is using the lowest GLP-1 dose possible to elicit gradual weight loss over time while optimizing diet, resistance exercise, etc
Those with a BMI of 35 or over may be eligible for bariatric surgery covered by Medicare
